This country profile provides an overview of South Sudan’s progress in reaching those in need of mass NTD treatment based on 2017 data.

*This includes all countries in Africa that are endemic for at least one of the five NTDs

Download country profile

Treatment coverage

Elephantiasis
7%
Blinding trachoma
5%
Intestinal worms
0%
Bilharzia
0%
River blindness
15%
1.1 million people received treatment in South Sudan in 2017 8.4 million people did not receive treatment in South Sudan in 2017

Priorities for progress in South Sudan

  • South Sudan is urged to identify the reasons for low coverage and fluctuating implementation.
  • It should build a consistent preventive chemotherapy programme for all five endemic diseases, with annual high coverage implementation, in all risk groups, as recommended by WHO.
  • Support the Expanded Special Project for Elimination of Neglected Tropical Diseases (ESPEN) established by WHO AFRO region for the elimination of these five diseases.

Elephantiasis

Treatment coverage increased from 0% in 2016 to 7% in 2017.

People needing treatment
5.15m
People receiving treatment
0.36m

Blinding trachoma

Treatment coverage decreased from 9% in 2016 to 5% in 2017.

People needing treatment
2.04m
People receiving treatment
0.1m

Intestinal worms

Treatment coverage decreased from 41% in 2016 to 0% in 2017.

Pre-sch and school-aged children needing treatment
4.81m
Pre-school and school-aged children receiving treatment
0m

Bilharzia

Treatment coverage decreased from 28% in 2016 to 0% 2017.

School-aged children needing treatment
1.55m
School-aged children receiving treatment
0m

River blindness

Treatment coverage was not reported in 2016 and 15% in 2017.

People needing treatment
7.53m
People receiving treatment
1.1m

The ESPEN portal (a World Health Organization AFRO region project) provides maps and district-level data for the preventive chemotherapy diseases in South Sudan.